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Abstract Phosphorylation of G protein-coupled receptors by ß-
adrenergic receptor kinases (ßARK) requires the presence of G 
protein ßy subunits. We have investigated the ability of the two 
ßARK isoforms to distinguish between defined recombinant ßy 
subunits. ßARK2 had an about 25% lower specific activity than 
ßARKl towards rhodopsin and the ß2-adrenergic receptor but 
the two kinases shared the selectivity for ßy subunits: ßy 
complexes consisting of ßi or ß2 in combination with Y2, ys, and 
¥i were more efficacious than those with y3 or ßiyi. Thus, while 
ßARKs differentiate between defined ßy subunits, ßy complexes 
do not discriminate between ßARK isoforms. 
Key words: ß-Adrenergic receptor kinase; ß2-Adrenergic 
receptor; Rhodopsin; G protein ßy subunit 
1. Introduction 
In the past few years a series of direct modulatory effects of 
G protein ßy subunits in signal transduction have been unrav-
elled [1,2]. The steadily increasing number of isoforms of ß 
and y subunits gave rise to the question whether subtype-de-
pendent selectivity can occur in their activities. Several at-
tempts with reconstituted proteins, however, revealed only 
minor differences in the interaction of ßy subunits with a 
subunits or various effectors [3,4]. 
Today, cDNAs for five ß subunits and 11 y subunits have 
been cloned from mammals [5,6]. While the ß subunits have a 
high degree of sequence identity, the sequences of the y sub-
units are more divergent. Thus, they are supposed to deter-
mine the specificity in the interactions of ßy complexes. In-
deed, the few cases of specific interactions discovered so far 
could be attributed to the isoform of the y subunit. In several 
functional assays ßiyi was less potent and efficacious than 
other combinations of ß and y subunits [3,4,7]. 
Among other effects, G protein ßy subunits have been 
shown to enhance receptor phosphorylation by the ß-adrener-
gic receptor kinases [8]. These kinases belong to the family of 
serine/threonine kinases called G protein-coupled receptor 
kinases (GRKs) currently consisting of six mammalian mem-
bers. According to their sequence similarity, GRKs are sepa-
rated into three subfamilies: (1) rhodopsin kinase (GRK1); 
(2) ßARKl and 2 (GRK2, 3); (3) GRK4, 5, 6. They phos-
phorylate agonist-bound G protein-coupled receptors and 
thereby initiate a process called homologous desensitization 
[9,10]. So far, the specificities of the various GRKs for recep-
tors are largely unknown. Thus, ßARKl, presumably the 
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physiologically relevant kinase for the ßiAR, is also able to 
phosphorylate a bulk of different G protein-coupled receptors 
including the photoreceptor rhodopsin [9,11,12]. 
Association with cell membranes is required for activity of 
the receptor kinases. Studies with ßARKl demonstrated that 
G protein ßy subunits as well as the binding of the pleckstrin-
homology domain of ßARK to phospholipids are responsible 
for its translocation from the cytosol to the membrane 
[8,13,14]. In a previous study, we found that the association 
of ßARKl with the ßy subunits is a crucial step for subtype-
specific interactions: the phosphorylation of G protein-
coupled receptors by ßARKl was enhanced differently by 
defined ßy dimers [15]. Phosphorylation of both rhodopsin 
and the ß2AR was more efficaciously enhanced by y2-contain-
ing combinations or a mixed preparation of ßy subunits from 
bovine brain than by dimers containing y3 or by transducin-
ßy, which is composed of ßiyi. 
ßARK2 is similar to ßARKl with an overall amino acid 
identity of 85% and is also regulated by G protein ßy subunits 
[16]. Nothing is known about potential coupling preferences 
of ßARK2 with ßy dimers. However, ßARK2 displays some 
receptor selectivity, e.g. olfactory tissues contain ßARK2, 
which has also been shown to be involved in desensitization 
of olfactory receptors while ßARKl is missing in these tissues 
[17,18]. This raises the possibility that ßARK2 also has pref-
erences for certain ßy complexes, and therefore it appeared 
interesting to investigate the ßy selectivity of this receptor 
kinase. In this study we measured in an in vitro system the 
ßARK2- versus ßARKl-mediated phosphorylation of rho-
dopsin and the ßaAR with various defined ßy dimers consist-
ing of combinations with ßi, ß2, yi, y2, Y3, ys, and Y7 and 
compared their activities on both ßARK isoforms. 
2. Materials and methods 
2.1. Production of recombinant proteins 
Recombinant G protein ßy subunits, bovine ßARKl and ßARK2 
were expressed using the baculovirus expression system [15,19]. The 
cDNAs for the y5 [20] and ^ [21] subunits were isolated from a bovine 
brain cDNA. PCR was performed with 30-mer oligonucleotide 
primers covering the 5' and 3' ends. The primers were flanked at their 
5' ends with restriction sites in order to facilitate subcloning of the 
cDNAs. The PCR products coding for y5 and ^ carried BamHI sites 
directly upstream of the start codons and EcoRI sites at their 3' ends 
and were cloned into the corresponding sites in the polylinker of the 
vector pVL1393 (BaculoGold, Dianova). 
For the expression of ßARK2 a 2.6 kb EcoRI fragment containing 
the open reading frame (2064 bp) was cloned into the EcoRI site of 
pVL1393. In order to remove the non-coding region upstream of the 
initiator ATG, the ßARK2-containing clone was digested with BamHI 
and Sfil. Subsequently, two complementary oligonucleotides repre-
senting the 5' end of ßARK2 were cloned into the vector in order 
to fill in the missing region, so that the initiator codon was directly 
downstream of the BamHI site. 
Purification of recombinant ßy complexes, ßyr and ßys was per-
formed as previously described [15]. Both ßARK isoforms were pur-
ified from Sf9 cells according to the same procedure [19]. 
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2.2. ADP-ribosylation of u0 
The ADP-ribosylation of cc0 by pertussis toxin in the presence of ßy 
subunits was performed as described earlier [15]. Briefly 1.6 pmol cc0 
(32 nM) purified from bovine brain were used in a reaction volume of 
50 ul in the presence of 600 ng of pertussis toxin, 1 uM [32P]NAD (18 
cpm/fmol) and increasing concentrations of ßy complexes (2-60 nM). 
Transferred mol [32P]ADP-ribose per mol oto was determined by liquid 
scintillation counting. 
2.3. Phosphorylation of rhodopsin and foAR 
Phosphorylation of urea-treated rod outer segments (0.83 u,M rho-
dopsin) was carried out with 5 nM ßARKl and 10 nM ßARK2, 
respectively, and various concentrations of ßy subunits (5-150 nM) 
as described [15]. For studying the ß2AR, High Five cells (Invitrogen) 
were infected with a recombinant baculovirus for this receptor at a 
multiplicity of infection of about 5 and harvested 72 h post infection. 
Membranes of ß2 AR-expressing insect cells were prepared as follows: 
800 ml of cell suspension were pelleted, resuspended in 20 ml of buffer 
A (20 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM EGTA, 100 uM 
PMSF, 10 |J,g/ml trypsin inhibitor, 30 ug/ml benzamidine, 5 |J,g/ml 
leupeptin) and homogenized with an Ultra Turrax and by passing 
5 times through 27-gauge needles. The homogenate was centrifuged 
at 40000Xg for 30 min at 4°C. Subsequently, the pellet was resus-
pended in buffer A, layered on top of a two-step sucrose gradient with 
25% (w/v) and 40% (w/v) sucrose in buffer A, and centrifuged at 
100 000 Xg for 90 min at 4°C in a Beckman SW41 rotor. The band 
between the two layers was collected, pelleted at lOOOOOXg for 30 
min and incubated with 5 M urea in buffer B (10 mM Tris-HCl pH 
7.5, 2 mM EDTA) for 30 min on ice. After thoroughly washing the 
membranes with buffer B, ß2AR was found to be enriched up to 200 
pmol/mg protein. Unless stated otherwise, membranes containing 
500-700 fmol ß2AR were phosphorylated by 45 nM ßARKl and 90 
nM ßARK2, respectively, in the presence of 150 nM ßy subunits. 
Rhodopsin bands were cut out from 12.5% polyacrylamide gels and 
the radioactivity was determined by Cerenkov counting whereas the 
intensities of ß2AR bands were evaluated using a Phosphorimager. 
3. Results 
Recombinant ßy dimers consisting of ßi, ß2, y2, Y3, Ys,
 ana" 
Y7, were expressed in insect cells by coinfection with baculo-
viruses encoding the respective subunits. Purified ßy subunits 
( > 95% homogeneity) were examined for their functional in-
tegrity by determining their ability to support the pertussis 
toxin-catalyzed ADP-ribosylation of ct0. All the defined ßy 
complexes tested were equally efficacious, and similar efficacy 
was seen with ßy subunits prepared from bovine brain or 
retina (Table 1). 
The expression and purification procedure for ßARK2 was 
Table 1 
Effects of ßy subunits on pertussis toxin-catalyzed ADP-ribosylation 
of oto 
ßy ADP-ribosylation (mol/mol a0) 
ßiy2 0.72 ±0.07 
ß2y2 0.70 ±0.01 
ßiy3 0.60 ±0.01 
ß2y3 0.62 ±0.07 
ßiy5 0.83 ±0.04 
ß2y5 0.75 ±0.13 
ßiy7 0.63 ±0.05 
ß2y7 0.76 ±0.11 
ßys 0.76 ±0.05 
ßyT 0.63 ±0.04 
None 0.21 ±0.02 
Pertussis toxin-catalyzed ADP-ribosylation of 1.6 pmol oc0 (32 nM) 
purified from bovine brain was measured in the absence or presence of 
3 pmol (60 nM) ßy complexes. ßyB denotes a preparation of ßy sub-
units from bovine brain; ßyp denotes transducin-ßy. Data are means 
and S.E.M. of three separate experiments. 
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Fig. 1. Enhancement of ßARK2-catalyzed rhodopsin phosphoryla-
tion by ßy subunits. Urea-treated rod outer segments (>95% rho-
dopsin) with 50 pmol rhodopsin were illuminated for 6 min under 
bright white light in a reaction volume of 60 JJ.1 and phosphorylated 
with 10 nM ßARK2 and increasing concentrations of ßy dimers (5-
150 nM). The rhodopsin bands were separated by SDS-PAGE, cut 
out and the incorporated 32P was determined by Cerenkov counting. 
The phosphorylation level by ßARK2 alone served as the control. 
Emax (% increase in phosphorylation over controls without ßy sub-
units) and EC50 values were calculated according to the Hill equa-
tion: ßye 783±38%, 17.0±3.2 nM; ßyr 302±58%, 15.8±11.9 nM; 
ßxy2 645173%, 17.9 ±7.7 nM; ß2y2 578156%; 8.913.9 nM; ß ^ 
316114%, 3.811.0 nM; ß2y3 366132%, 7.613.2 nM. Data are 
means 1 S.E.M. of three independent experiments. 
adapted from that for ßARKl [19] and resulted in prepara-
tions of > 90% purity (not shown). Due to its higher isoelec-
tric point, ßARK2 eluted at 140 mM NaCl from the CM-
Fractogel matrix, whereas ßARKl already eluted at 100 
mM NaCl [19]. The concentrations of ßARKl and 2 were 
determined from Coomassie blue R250-stained polyacryl-
amide gels in order to apply equal amounts in the functional 
assays. 
We investigated the selectivity of ßARK2 for defined ßy 
combinations in a phosphorylation assay with rhodopsin as 
the substrate. Concentration-response curves revealed clear 
differences between the ßy subunits in their ability to activate 
ßARK2 (Fig. 1). ßiy2 and ß2y2 were more efficacious («600% 
stimulation) than combinations with Y3 or transducin-ßy 
(j=350%). ßye caused even greater stimulation than the y2-
containing dimers. These results are similar to those observed 
with ßARKl, although the differences between the maximum 
effects of the y2- and y3-containing ßy subunits were less pro-
nounced for ßARK2 than for ßARKl where the differences 
were more than 3-fold [15]. 
In order to compare the effects of a larger number of ßy 
complexes, we determined the effects of a constant concentra-
tion of various ßy subunits on ßARKl- and ßARK2-mediated 
phosphorylation of rhodopsin. We chose a ßy concentration 
of 50 nM which evoked a submaximal effect. Patterns of ac-
tivation caused by the different ßy complexes reflected the 
data obtained in the concentration-response curves: ßy dimers 
with Y3 and yi had smaller effects than combinations with y2, 
75. Y7 (Fig- 2A,B). For both receptor kinases the enhancement 
by effective combinations such as ß2Y5 was 3-fold higher than 
by ßyr and about 2-fold higher than by y3-containing ßy sub-
units. The pattern of ßy-mediated enhancement of rhodopsin 
phosphorylation was very similar for ßARKl (Fig. 2A) and 
ßARK2 (Fig. 2B). 
We then compared the ability of ßARKl and ßARK2 to 
phosphorylate the ß2AR. In the presence of 100 uM isopro-
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Fig. 2. Phosphorylation of rhodopsin by ßARKl and ßARK2 with 
a constant concentration of ßy subunits. Urea-treated rod outer seg-
ments with 50 pmol rhodopsin were phosphorylated with ßARKl 
(A) or ßARK2 (B) in the presence of 50 nM of defined ßy dimers. 
ßyx was purified from bovine retina and is defined as ßiyi. Data 
are means ± S.E.M. of three independent experiments. 
terenol there was very little ß2AR phosphorylation in the 
receptor-containing membranes by ßARKl or ßARK2 in 
the absence of ßy subunits; phosphorylation by ßARK2 was 
about 40% lower than by ßARKl although 2-fold higher con-
centrations of ßARK2 were used (Fig. 3). In the presence of 
the ß-adrenergic antagonist propranolol there was no signifi-
cant receptor phosphorylation. The addition of bovine brain-
ßy subunits stimulated the phosphorylation by both receptor 
kinases. The enhancement with a 10-fold excess of ßy subunits 
over ßARK was 3-fold for ßARKl and 2.5-fold for ßARK2. 
Thus, the ßy-effect was slightly lower when using cell mem-
branes compared to ß2AR reconstituted in lipid vesicles where 
we had measured 5-6-fold enhancements [15]. Similar to the 
assays with rhodopsin as the substrate, transducin-ßy caused 
only a minor increase in receptor phosphorylation. 
Then we investigated the effects of various ßy dimers on the 
ability of ßARKl and ßARK2 to phosphorylate the ß2AR. 
Because higher concentrations of ßARK were needed in these 
experiments, a greater concentration of ßy subunits was re-
quired for submaximum effects (data not shown), and there-
fore we applied a concentration of 150 nM of ßy subunits in 
these comparisons. We observed similar effects of the various 
ßy complexes on ßARK-mediated phosphorylation of the 
ß2AR to those seen in the assays with rhodopsin. The differ-
ences in efficacy, however, were less pronounced (Fig. 4A,B). 
Again, y2-, 75-, and y7-containing ßy dimers were more effica-
cious than combinations with y3 or yi • This pattern of activa-
tion was similar for both receptor kinase isoforms. 
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4. Discussion 
The reasons for the existence of many homologous isoforms 
of G protein ß and y subunits have so far not been discovered 
in reconstitution assays with defined ßy dimers. These inves-
tigations mostly failed to show clear differences in the inter-
actions with other proteins except for most effects of ßyr 
(ßiYi) [15,22] and except for the ßy-enhanced phosphorylation 
of G protein-coupled receptors by ßARKl [15]. In the present 
study, data for ßARK2, the second ßy-dependent receptor 
kinase known so far, underline that this phosphorylation 
process depends on the composition of the ßy complex. 
Compared to ßARKl, recombinant ßARK2 was character-
ized by a somewhat lower basal activity and a weaker stimu-
latory effect of the ßy subunits towards rhodopsin and the 
ß2AR. This confirms expression studies in COS 7 cells [16] 
but contrasts with data from reconstitution assays where iden-
tical activities, Km and Vm&x values were reported for both 
isoforms [23]. 
Phosphorylation of rhodopsin and ß2AR by ßARK2 fol-
lowed a similar pattern to that we had observed for ßARKl 
[15]: ßiy2, ß2y2, and ßye showed stronger enhancement than 
ßiY3> ß2Y3, or ßyT. The new combinations containing y5 and y7 
belonged to the efficacious group of ßy complexes. Differences 
between efficacies of the defined ßy combinations were less 
obvious in experiments with ß2AR than with rhodopsin or 
in earlier studies with reconstitution of purified receptors. 
This might be due to stimulatory effects of endogenous ßy 
subunits, phospholipids or kinases still residing in the cell 
membranes. The differences in the efficacies of various ßy 
dimers were slightly smaller for ßARK2 than for ßARKl, 
but the overall pattern of ßy enhancement was very similar 
for the two receptor kinases. Thus, even though the various ßy 
combinations evoked varying effects in our assays, none of 
them appeared to be capable of distinguishing between 
ßARKl and ßARK2. 
Our results suggest that it is the y subunit which may act as 
the selectivity-determining component of ßy complexes in 
these interactions. This might be ascribed to the greater diver-
gence of the amino acid sequences of y subunits. Since there 
are no data about colocalization of ßy subunits and GRKs, or 
functional consequences in vivo, the physiological relevance of 
this specificity remains to be studied. On the other hand, there 
Fig. 3. ßy-mediated enhancement of ß2AR phosphorylation by 
ßARKl or ßARK2. Urea-treated plasma membranes of Sf9 cells 
with 500 fmol ß2AR (12.5 nM) were stimulated with 100 uM iso-
proterenol (I) or treated with 10 uM of the ß-adrenergic antagonist 
propranolol (P) and phosphorylated by 100 nM of purified ßARKl 
or ßARK2 in the absence or presence of 150 nM ßy subunits (B, 
bovine brain-ßy; T, transducin-ßy). Basal levels of phosphorylation 
were determined with ß2AR membranes without addition of ßARK 
or ßy subunits. The membranes were separated by SDS-PAGE and 
phosphorylation of ß2AR was visualized by autoradiography. 
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Fig. 4. Phosphorylation of ß2AR by ßARKl and ßARK2 with a 
constant concentration of ßy subunits. Urea-treated plasma mem-
branes of High Five cells with 600-800 fmol ß2AR were phospho-
rylated in the presence of 100 uM isoproterenol for 30 min at 30°C 
by ßARKl (A) or ßARK2 (B) in the presence of 150 nM ßy 
dimers. ß2AR membranes were separated by SDS-PAGE and the in-
corporated radioactivity was determined by phosphorimaging. ßyT 
(transducin- ßy) is defined as ßiyi. Data are means of three inde-
pendent experiments. 
was no selectivity of the ßy subunits for the ßARK isoform. 
While the high degree of amino acid identity of these kinases 
(85%) may explain this finding, the reason for the existence of 
the ßARK isoforms remains still unclear. 
Selectivity of the kinase isoforms might originate from di-
vergent localizations, but ßARK2 was found to have nearly 
the same tissue distribution as ßARKl, although mRNA sig-
nals from ßARK2 were much lower in most organs [16]. An 
exception may be the olfactory tissues where convincing evi-
dence has been found that ßARKl is missing while ßARK2 is 
strongly expressed and mediates desensitization of olfactory 
receptors [17,18]. Since very recently a y isoform, yg [24], has 
been found to be exclusively expressed in olfactory and vo-
meronasal tissues, it will be interesting to see whether ßy com-
binations with y8 will have divergent effects on ßARK2-
mediated phosphorylations. Other ßy complexes which might 
be able to differentiate between ßARK isoforms are those 
which are involved in endosóme fusion. In this system pep-
tides corresponding to the carboxy-termini of ßARKl and 2 
differed in their potencies and efficacies to inhibit the fusion 
[25]. 
Receptor selectivity might be another difference between the 
ßARK isoforms, but information on this issue is likewise 
scant. Studies about the specificity of the various receptor 
kinases for particular G protein-coupled receptors have been 
performed mainly in vitro with recombinant purified or par-
tially purified proteins. Similar activities for ßARKl and 
ßARK2 towards several receptors, e.g. towards rhodopsin, 
S. Müller et al.lFEBS Letters 401 (1997) 25-29 
ß2AR, muscarinic M2 cholinergic receptor, and OCÍB- or 0C2B 
adrenergic receptor [23,26-28] could be detected in most cases 
whereas differences were observed for the iV-formyl peptide 
receptor and substance P receptor where ßARK2 had a 50% 
lower activity [29] or 50% higher activity, respectively [30]. 
Cellular responses revealed that ßARK2 selectively blunted 
thrombin receptor-mediated Ca2+ influx [31] or relieved the 
inhibition of N-type calcium channels in sensory neurons after 
stimulation with norepinephrine which is presumably 
mediated by 0C2AR [32]. 
These data may indicate that selectivities in receptor signal-
ling may be much higher in intact complex systems than in 
isolated reconstituted assays. Similar conclusions may be in-
ferred for the specificity of G protein ßy subunits in receptor 
to effector signalling where experiments with anti-sense oligo-
nucleotides in intact cells [33-37] suggest much higher selec-
tivities than biochemical assays with purified components 
[3,4,7,22]. Selectivity may thus reside in multiple determinants 
in receptor systems, even though - such as in the present 
report - some selectivity may already be apparent in the direct 
protein-protein interactions that can be observed in reconsti-
tuted systems. 
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